Cambrian Biopharma Inc - Net Worth and Insider Trading
Cambrian Biopharma Inc Net Worth
The estimated net worth of Cambrian Biopharma Inc is at least $4 Million dollars as of 2024-05-31. Cambrian Biopharma Inc is the 10% Owner of Sensei Biotherapeutics Inc and owns about 5,231,488 shares of Sensei Biotherapeutics Inc (SNSE) stock worth over $4 Million. Details can be seen in Cambrian Biopharma Inc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Cambrian Biopharma Inc has not made any transactions after 2022-03-02 and currently still holds the listed stock(s).
Transaction Summary of Cambrian Biopharma Inc
Cambrian Biopharma Inc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cambrian Biopharma Inc owns 1 companies in total, including Sensei Biotherapeutics Inc (SNSE) .
Click here to see the complete history of Cambrian Biopharma Inc’s form 4 insider trades.
Insider Ownership Summary of Cambrian Biopharma Inc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SNSE | Sensei Biotherapeutics Inc | 2023-07-31 | 10 percent owner & other: See Remarks |
Cambrian Biopharma Inc Latest Holdings Summary
Cambrian Biopharma Inc currently owns a total of 1 stock. Cambrian Biopharma Inc owns 5,231,488 shares of Sensei Biotherapeutics Inc (SNSE) as of March 2, 2022, with a value of $4 Million.
Latest Holdings of Cambrian Biopharma Inc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNSE | Sensei Biotherapeutics Inc | 2022-03-02 | 5,231,488 | 0.76 | 3,949,773 |
Holding Weightings of Cambrian Biopharma Inc
Cambrian Biopharma Inc Form 4 Trading Tracker
According to the SEC Form 4 filings, Cambrian Biopharma Inc has made a total of 41 transactions in Sensei Biotherapeutics Inc (SNSE) over the past 5 years, including 41 buys and 0 sells. The most-recent trade in Sensei Biotherapeutics Inc is the acquisition of 1,203 shares on March 2, 2022, which cost Cambrian Biopharma Inc around $3,850.
Insider Trading History of Cambrian Biopharma Inc
- 1
Cambrian Biopharma Inc Trading Performance
GuruFocus tracks the stock performance after each of Cambrian Biopharma Inc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cambrian Biopharma Inc is -44.56%. GuruFocus also compares Cambrian Biopharma Inc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cambrian Biopharma Inc within 3 months outperforms 0 times out of 41 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Cambrian Biopharma Inc's insider trading performs compared to the benchmark.
Performance of Cambrian Biopharma Inc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -16.75 | | | | | |
| Relative Return to S&P 500(%) | -17.27 | | | | | |
Cambrian Biopharma Inc Ownership Network
Cambrian Biopharma Inc Owned Company Details
What does Sensei Biotherapeutics Inc do?
Who are the key executives at Sensei Biotherapeutics Inc?
Cambrian Biopharma Inc is the 10 percent owner & other: See Remarks of Sensei Biotherapeutics Inc. Other key executives at Sensei Biotherapeutics Inc include Chief Business Officer Stephanie Krebs , director & President & CEO John Celebi , and director & 10 percent owner James Peyer .
Sensei Biotherapeutics Inc (SNSE) Insider Trades Summary
Over the past 18 months, Cambrian Biopharma Inc made no insider transaction in Sensei Biotherapeutics Inc (SNSE). Other recent insider transactions involving Sensei Biotherapeutics Inc (SNSE) include a net sale of 3,439,461 shares made by Apeiron Investment Group Ltd. , and a net purchase of 500 shares made by John Celebi .
In summary, during the past 3 months, insiders sold 0 shares of Sensei Biotherapeutics Inc (SNSE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,441,661 shares of Sensei Biotherapeutics Inc (SNSE) were sold and 2,700 shares were bought by its insiders, resulting in a net sale of 3,438,961 shares.
Sensei Biotherapeutics Inc (SNSE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sensei Biotherapeutics Inc Insider Transactions
Cambrian Biopharma Inc Mailing Address
Above is the net worth, insider trading, and ownership report for Cambrian Biopharma Inc. You might contact Cambrian Biopharma Inc via mailing address: 228 Park Avenue S., #66643, New York Ny 10003.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
